Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

43,499 stories, page 561 of 725

Advanced search

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

Market Movers Today: PepsiCo Earnings Miss, SK Hynix ADR Surge, AstraZeneca Trial Fails, and Oil Retreats

BlockonomiOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

AstraZeneca Signs USD 2.1 Billion COPD Drug Licensing Deal with Sino Biopharm Unit

Medical DialoguesOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

FDA Greenlights Ennumo: New Supportive Care Option for Oncology Nurses

Oncology Nursing NewsOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

Biotech Stock Arcutis Climbs Into Buy Zone As FDA Mulls Expanded Use For Key Skin Treatment

Investor's Business DailyOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

FDA grants tegacorat orphan, rare pediatric disease status for DMD

Contemporary PediatricsOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

The Motley FoolOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

FDA greenlights phase 1 study of UGN-501 for NMIBC

Urology TimesOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

Stocks Look Shaky, But This Sector is Booming (Biotech)

Yahoo FinanceOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

Mumbai's iconic K Rustom ice cream outlet shut after rats, expired stock found

Khaleej TimesOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

Why the Direct Model is the Future of Pharma(1)

Pharmaceutical CommerceOriginal source

🌍Jul 10Researchopenclinica.comTier 2 · Direct publisher

Introducing Study Hub: One Connected Platform for the Entire Clinical Trial Participant Journey

OpenClinicaOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

Stocks Look Shaky, But This Sector is Booming (Biotech)

Zacks Investment ResearchOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

aol.comOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

A Shot Every Two Weeks Instead of Weekly: New GLP-1 Drug Shows Strong Trial Results

Medical DailyOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Why the Pharmacy Experience Matters for GLP-1 Outcomes

Pharmaceutical CommerceOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

Yahoo FinanceOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Anti-VEGF Biosimilars Match Reference Drug in Indian Retinal Disease Care

Center for BiosimilarsOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Vivani's Semaglutide Implant Advances to Human Testing

AllSciOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

As Ramaswamy vacations in Europe, biotech he founded collects $950M COVID vaccine payment

TiffinOhio.netOriginal source

🌍Jul 9discoverynews.google.comTier 2 · Trade media

Arialys Therapeutics Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of Anti-NMDA Receptor Encephalitis

BioSpaceOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Depression Drug Approved by FDA Had 11 Failed Trials and an Advisory Committee Vote Against Approval

Mad In AmericaOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Biocon Announces Peer-Reviewed Data Supporting Yesafili in Diabetic Macular Edema

Eyewire+Original source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

NHS Resolution annual report and accounts: 2025 to 2026

Annual report and accounts from NHS Resolution covering 1 April 2025 to 31 March 2026.

UK Department of Health and Social CareOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Structuring Tech Transfer for Optimized Collaboration

PharmTech.comOriginal source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

UK Health Security Agency (UKHSA) research involving animals

UKHSA and Porton Biopharma Limited have committed to being more transparent with the public about wh...

UK Health Security AgencyOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Millions of risky eye drops recalled, what to do now

Rolling OutOriginal source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

UK Clinical Research Delivery key performance indicators: data to June 2026

Report bringing together data on the delivery of globally competitive clinical research through the...

UK Department of Health and Social CareOriginal source

🌍Jul 9discoverynews.google.comTier 2 · Trade media

Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine

Fierce PharmaOriginal source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

Marburg and Ebola contact tracing matrix

How to classify and manage people who have been exposed to Ebola disease or Marburg virus disease.

UK Health Security AgencyOriginal source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

Crimean-Congo haemorrhagic fever (CCHF) contact tracing matrix

How to classify and manage people who have been exposed to CCHF.

UK Health Security AgencyOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Paxlovid Safe for Children Aged 6 And Older, New Study Finds

Health and MeOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Regulators push Amgen to withdraw drug due to data manipulation

Chemistry WorldOriginal source

🇺🇰Jul 9Researched.ac.ukTier 2 · Direct publisher

Pioneering spacewalking astronaut awarded honorary degree

University of EdinburghOriginal source

🌍Jul 9discoverynews.google.comTier 2 · Trade media

Prime wins Beam arbitration, clearing path to clinic

STATOriginal source

🌍Jul 9discoverynews.google.comTier 2 · Trade media

Lilly was already pharma's biggest company. Now it's doing deals to match

Endpoints NewsOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Serum Institute of India ties up with DNDi for Phase III trial of dengue therapy

The Indian ExpressOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A – SZSE:002603

TradingViewOriginal source

🇫🇷Jul 9Regulatoryleem.orgTier 1 · Regulatory source

16 tonnes de produits de santé acheminées vers Kharkiv et plusieurs autres villes ukrainiennes.

LEEM FranceOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Biotech executive Keating named to board of Berkeley Heights biopharma Kalaris

ROI-NJOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

AstraZeneca, Ionis Shares Slide After Wainua Misses Target in Heart Disease Trial

WSJOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Yahoo FinanceOriginal source

🌍Jul 9discoverynews.google.comTier 2 · Trade media

Why biotech revenue projections ‘won’t look as sunny’ once Trump tax bill hits Medicaid enrollment

Fierce BiotechOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, Inc. Stock 12‑Month Price Target Raised to $370.23, Implies 5% Upside

TradingViewOriginal source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

Health Research Authority annual report and accounts 2025 to 2026

The report explains what the Health Research Authority (HRA) does, what it achieved and some of the...

UK Department of Health and Social CareOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Arialys Therapeutics Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of Anti-NMDA Receptor Encephalitis

Business WireOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Roche ends two Huntington’s disease drug programmes after disappointing results

HDBuzz – Huntington’s disease research news.Original source

🇺🇸Jul 9Devicesviz.aiTier 1 · Company source

Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration

Viz.aiOriginal source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

Weekly all-cause mortality surveillance: 2025 to 2026

How the actual number of deaths in England compare with the expected numbers of deaths for each week...

UK Health Security AgencyOriginal source

🌍Jul 9discoverynews.google.comTier 2 · Trade media

AstraZeneca, Ionis slip as ATTR-CM drug fails Phase 3

BioSpaceOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

WST Completes SmartDose Sale to AbbVie to Focus on Core Growth

TradingViewOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

AstraZeneca licenses Sino Biopharma respiratory drug in $200 million upfront deal

The Pharma LetterOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate

The Manila TimesOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Opus Genetics expects September data from gene therapy trial By Investing.com

Investing.com IndiaOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?

Yahoo FinanceOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Rare skin disease gets first company-backed clinical trial as Quoin wins FDA clearance

Stock TitanOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

FDA clears Fate Therapeutics' FT839 for autoimmune trial push

Stock TitanOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate

GlobeNewswireOriginal source

🌍Jul 9discoverynews.google.comTier 2 · Trade media

AstraZeneca, Ionis drug fails big heart disease study in major setback

BioPharma DiveOriginal source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

Annual epidemiological commentary: Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections, up to and including financial year 2026 to 2027

Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infect...

UK Health Security AgencyOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

CA-AUXILIUM-BIOTECH

The FactsOriginal source